Capital Flow Monitor · Sponsors · CIK 1786949

Sparrow Pharmaceuticals, Inc.

1050 Southwest 6th Street, PORTLAND, OR, 97204 · 6174650328

Pharmaceuticals · Corporation· inc. DELAWARE true

Fit score

—

Offering

$121.4M

Sold

$61.8M

% sold

50.9%

Investors

17

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2025-07-01 D ·current 506(b) $121.4M $61.8M 50.9% 17 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.